BCL2 and malignant colon neoplasm: Similarly, TMA immunohistochemical staining for p53, cyclin D1, bcl-2, bax, Cox-2, β-catenin, c-myc, PTEN and p-Akt1enabled high-throughput analysis of genetic alterations that might contribute to human colon cancer development and progression (12).